Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

The recent wave of pharmaceutical tragedies in Sri Lanka, as well as some others that have occurred regularly in the past, ...

This year’s influenza virus has been dubbed the “super flu” for how quickly it’s spreading — and how hard it’s hitting.

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

The National Institute for Health and Care Excellence (NICE) has recommended amivantamab (Rybrevant) plus lazertinib ...

When the flu strikes, it can feel relentless: rising fever, hacking cough, stuffy nose and sore throat. For many people, relief can come in the form of Tamiflu, a prescription antiviral medication ...

The life-threatening drug, medetomidine, has been found in 457 drug seizures in the third quarter of this year, a surge from ...

UTIs are among the most common bacterial infections worldwide, but inappropriate use and overuse of antibiotics is driving ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

Norovirus is the country's leading cause of vomiting, diarrhea, and foodborne illness, and right on schedule, it's picking up ...

Chronic vomiting in cats isn’t normal. Learn the common causes—from hairballs and food sensitivities to IBD and metabolic disease.

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.